Vertebrate embryos as tools for anti-angiogenic drug screening and function
| dc.contributor.author | Beedie, Shaunna | |
| dc.contributor.author | Diamond, Alexandra J. | |
| dc.contributor.author | Rosa Fraga, Lucas | |
| dc.contributor.author | Figg, William D. | |
| dc.contributor.author | Vargesson, Neil | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2017-12-06T17:40:42Z | |
| dc.date.available | 2017-12-06T17:40:42Z | |
| dc.date.embargoedUntil | 2017-11-22 | |
| dc.date.issued | 2017-06-01 | |
| dc.description | Shaunna Beedie is a recipient of a Wellcome Trust-NIH PhD Studentship (Grant number 098252/Z/12/Z). Alexandra J. Diamond is a recipient of a BBSRC EastBIO DTP PhD Scholarship. Lucas Rosa Fraga is a recepient of a PhD scholarship from the Science Without Borders program – CNPq Brazil – INAGEMP/ Grant CNPq 573993/2008-4 Shaunna Beedie and William D. Figg are supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organization imply endorsement by the U.S. Government. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 237193 | |
| dc.identifier | 72932908 | |
| dc.identifier | 3d6b8125-567f-4cab-862b-4d592acf7cc2 | |
| dc.identifier | 85007287409 | |
| dc.identifier | 27888069 | |
| dc.identifier.citation | Beedie, S, Diamond, A J, Rosa Fraga, L, Figg, W D & Vargesson, N 2017, 'Vertebrate embryos as tools for anti-angiogenic drug screening and function', Reproductive Toxicology, vol. 70, pp. 49-59. https://doi.org/10.1016/j.reprotox.2016.11.013 | en |
| dc.identifier.doi | 10.1016/j.reprotox.2016.11.013 | |
| dc.identifier.issn | 0890-6238 | |
| dc.identifier.other | ORCID: /0000-0001-8027-114X/work/145270741 | |
| dc.identifier.uri | http://hdl.handle.net/2164/9670 | |
| dc.identifier.vol | 70 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Reproductive Toxicology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | angiogenesis | en |
| dc.subject | chicken | en |
| dc.subject | zebrafish | en |
| dc.subject | mouse | en |
| dc.subject | rat | en |
| dc.subject | rabbit | en |
| dc.subject | non-human primates | en |
| dc.subject | thalidomide | en |
| dc.subject | R Medicine | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | 098252/Z/12/Z | en |
| dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
| dc.subject.lcc | R | en |
| dc.title | Vertebrate embryos as tools for anti-angiogenic drug screening and function | en |
| dc.type | Journal article | en |
